Literature DB >> 16442461

Beyond clinical trials and narratives: a participatory action research with cancer patient self-help groups.

Donna Kam Pun Wong1, Sau Fong Chow.   

Abstract

The self-help movement in Hong Kong has been gradually gaining its momentum in recent years. The primary purpose of the research was to give voice to the experiences and views of patients towards cancer care and to influence healthcare providers and policy makers to act on patients' agendas. Self-help groups and their members are mobilized through the research activities of focus groups, interviews and a patient forum to specify and act on their needs. This article describes the project and the participatory action research (PAR) strategies in the mobilization of, and collaboration with, patient groups in research design, data analysis, and dissemination of findings. The implications on healthcare practice, particularly within an era of reform and restructuring of the healthcare system, are discussed.

Entities:  

Mesh:

Year:  2006        PMID: 16442461     DOI: 10.1016/j.pec.2004.11.016

Source DB:  PubMed          Journal:  Patient Educ Couns        ISSN: 0738-3991


  3 in total

1.  Closing the loop: action research in a multimodal hereditary cancer patient conference is an effective tool to assess and address patient needs.

Authors:  Carin R Espenschied; Deborah J MacDonald; Julie O Culver; Sharon Sand; Karen Hurley; Kimberly C Banks; Jeffrey N Weitzel; Kathleen R Blazer
Journal:  J Cancer Educ       Date:  2012-06       Impact factor: 2.037

2.  Beyond the therapeutic: A Habermasian view of self-help groups' place in the public sphere.

Authors:  Sarah Chaudhary; Mark Avis; Carol Munn-Giddings
Journal:  Soc Theory Health       Date:  2012-10-10

Review 3.  Lifestyle Interventions through Participatory Research: A Mixed-Methods Systematic Review of Alcohol and Other Breast Cancer Behavioural Risk Factors.

Authors:  Jessica A Thomas; Emma R Miller; Paul R Ward
Journal:  Int J Environ Res Public Health       Date:  2022-01-16       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.